These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27102441)

  • 41. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1.
    Han S; Shi Y; Sun L; Liu Z; Song T; Liu Q
    Int J Biol Sci; 2019; 15(13):2936-2947. PubMed ID: 31853229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4.
    Eggers JC; Martino V; Reinbold R; Schäfer SD; Kiesel L; Starzinski-Powitz A; Schüring AN; Kemper B; Greve B; Götte M
    Reprod Biomed Online; 2016 Apr; 32(4):434-45. PubMed ID: 26854065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma.
    Dong X; Han Y; Zhang E; Wang Y; Zhang P; Wang C; Zhong L; Li Q
    Aging (Albany NY); 2021 Apr; 13(7):10603-10618. PubMed ID: 33833131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis.
    Wang Y; Zuo D; Huang Z; Qiu Y; Wu Z; Liu S; Zeng Y; Qiu Z; He W; Li B; Yuan Y; Niu Y; Qiu J
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repression of microRNA-130b by thyroid hormone enhances cell motility.
    Lin YH; Wu MH; Liao CJ; Huang YH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Tsai MM; Chen CY; Lin TP; Yeh YH; Chen WJ; Lin KH
    J Hepatol; 2015 Jun; 62(6):1328-40. PubMed ID: 25617495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
    Yang YM; Lee WH; Lee CG; An J; Kim ES; Kim SH; Lee SK; Lee CH; Dhanasekaran DN; Moon A; Hwang S; Lee SJ; Park JW; Kim KM; Kim SG
    Oncogene; 2015 May; 34(22):2910-21. PubMed ID: 25065598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.
    Zhang D; Zhou P; Wang W; Wang X; Li J; Sun X; Zhang L
    Oncol Rep; 2016 Jan; 35(1):366-74. PubMed ID: 26499912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.
    Cao J; Liu J; Long J; Fu J; Huang L; Li J; Liu C; Zhang X; Yan Y
    Biomed Pharmacother; 2017 May; 89():642-650. PubMed ID: 28262617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster.
    Li XL; Hara T; Choi Y; Subramanian M; Francis P; Bilke S; Walker RL; Pineda M; Zhu Y; Yang Y; Luo J; Wakefield LM; Brabletz T; Park BH; Sharma S; Chowdhury D; Meltzer PS; Lal A
    Mol Cell Biol; 2014 Feb; 34(3):533-50. PubMed ID: 24277930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM; Yang H; Fang F; Xu JF; Yang LY
    Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SOX5 promotes epithelial-mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma.
    Wang D; Han S; Wang X; Peng R; Li X
    Med Oncol; 2015 Feb; 32(2):461. PubMed ID: 25572815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
    Sureban SM; Madhoun MF; May R; Qu D; Ali N; Fazili J; Weygant N; Chandrakesan P; Ding K; Lightfoot SA; Houchen CW
    Oncotarget; 2015 Nov; 6(35):37200-15. PubMed ID: 26468984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
    Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
    Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.